Home / Posts on the theme News

Étiquette : News

Careers

Invectys Inc. is a biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancers based in Paris. Invectys develops…

Read more

Invectys Inc. to participate in the 2021 Roth Virtual H...

Invectys Inc. to participate in the 2021 Roth Virtual Healthcare Private Company Forum on June 28th, 2021   Houston, TX, USA, May 4, 2021 (GLOBE NEWSWIRE) –…

Read more

Invectys nominates Rosemary Williams, CPA, as Vice-Pres...

Invectys nominates Rosemary Williams, CPA, as Vice-President for Administration and Controller Houston, TX, USA, June 1st, 2021 (GLOBE NEWSWIRE) — Invectys…

Read more

Invectys, Inc appoints Biopharma Veteran, Praveen Tyle,...

Invectys, Inc appoints Biopharma Veteran, Praveen Tyle, PhD as President & CEO   Houston, TX, USA, May 4, 2021 (GLOBE NEWSWIRE) – Invectys, Inc., a clinical-stage…

Read more

AACR Annual Meeting 2021

AACR Annual Meeting 2021 April 10th – 15th 2021   Invectys was at the AACR’s Annual Meeting 2021. Although online, the AACR Annual Meeting still carried…

Read more

Invectys reports in vivo efficacy of its pan anti-tumor...

Invectys reports in vivo efficacy of its pan anti-tumor anti-HLA-G CAR-T cells These results open new perspectives in oncology for targeting cancer through HLA-G,…

Read more

Invectys publishes positive clinical results for its IN...

Invectys publishes positive clinical results for its INVAC-1 Phase I Study in Clinical Cancer Research   With an extended Phase I and a new delivery method…

Read more

2019 ESMO Immuno-Oncology Congress

ESMO Immuno-Oncology Congress 2019 December 11th – 14th 2019 Palexpo, Geneva, Switzerland Invectys will be attending the 2019 ESMO Immuno-Oncology Congress. From…

Read more